News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
812,556 Results
Type
Article (62402)
Company Profile (455)
Press Release (749683)
Multimedia
Podcasts (179)
Webinars (27)
Section
Business (221488)
Career Advice (2926)
Deals (38079)
Drug Delivery (167)
Drug Development (88296)
Employer Resources (185)
FDA (17921)
Job Trends (16492)
News (376823)
Policy (36819)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (3012)
Academic (1)
Accelerated approval (58)
ADA (49)
Adcomms (40)
Allergies (208)
Alliances (54185)
ALS (242)
Alzheimer's disease (1980)
Antibody-drug conjugate (ADC) (568)
Approvals (18318)
Artificial intelligence (819)
ASCO (345)
Autoimmune disease (370)
Automation (66)
Bankruptcy (399)
Best Places to Work (12422)
BIO (72)
BIOSECURE Act (21)
Biosimilars (250)
Biotechnology (306)
Bladder cancer (214)
Brain cancer (84)
Breast cancer (850)
Cancer (6669)
Cardiovascular disease (558)
Career advice (2493)
Career pathing (53)
CAR-T (384)
CDC (71)
Celiac Disease (3)
Cell therapy (1050)
Cervical cancer (58)
Clinical research (76651)
Collaboration (2398)
Commercialization (1)
Company closure (6)
Compensation (1525)
Complete response letters (106)
COVID-19 (3009)
CRISPR (128)
C-suite (1328)
Cystic fibrosis (166)
Data (8882)
Decentralized trials (3)
Denatured (60)
Depression (198)
Dermatology (100)
Diabetes (704)
Diagnostics (7476)
Digital health (68)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (404)
Drug pricing (238)
Drug shortages (36)
Duchenne muscular dystrophy (329)
Earnings (96541)
Editorial (79)
Employer branding (23)
Employer resources (166)
Events (131732)
Executive appointments (1213)
FDA (22090)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1980)
Gene editing (275)
Generative AI (73)
Gene therapy (837)
GLP-1 (1256)
Government (5333)
Grass and pollen (8)
Guidances (424)
Healthcare (20880)
Hematology (197)
HIV (99)
Huntington's disease (68)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (116)
Immunology and inflammation (356)
Immuno-oncology (119)
Indications (225)
Infectious disease (3409)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (152)
Intellectual property (330)
Interviews (566)
IPO (17465)
IRA (60)
Job creations (4394)
Job search strategy (2014)
JPM (70)
Kidney cancer (22)
Labor market (113)
Layoffs (664)
Leadership (54)
Legal (9098)
Liver cancer (111)
Longevity (37)
Lung cancer (885)
Lymphoma (487)
Machine learning (68)
Management (65)
Manufacturing (1223)
Marketing (4)
MASH (228)
Medical affairs (1)
Medical device (15155)
Medtech (15337)
Mergers & acquisitions (21929)
Metabolic disorders (1817)
mRNA (269)
Multiple sclerosis (210)
NASH (24)
Neurodegenerative disease (517)
Neuropsychiatric disorders (130)
Neuroscience (3757)
Neurotech (1)
NextGen: Class of 2026 (7403)
Non-profit (5022)
Now hiring (82)
Obesity (858)
Opinion (364)
Ovarian cancer (248)
Pain (285)
Pancreatic cancer (370)
Parkinson's disease (426)
Partnered (38)
Patents (670)
Patient recruitment (806)
Peanut (72)
People (65932)
Pharmaceutical (78)
Pharmacy benefit managers (35)
Phase 1 (23866)
Phase 2 (33600)
Phase 3 (25045)
Pipeline (10147)
Policy (386)
Postmarket research (3040)
Preclinical (10334)
Press Release (72)
Prostate cancer (351)
Psychedelics (72)
Radiopharmaceuticals (374)
Rare diseases (1301)
Real estate (6728)
Recruiting (78)
Regulatory (28628)
Reports (57)
Research institute (2720)
Resumes & cover letters (460)
Rett syndrome (47)
RNA editing (31)
RSV (96)
Schizophrenia (197)
Series A (340)
Series B (250)
Service/supplier (14)
Sickle cell disease (130)
Special edition (32)
Spinal muscular atrophy (185)
Sponsored (51)
Startups (4106)
State (2)
Stomach cancer (21)
Supply chain (145)
Tariffs (98)
The Weekly (116)
Vaccines (1285)
Venture capital (138)
Weight loss (582)
Women's health (147)
Worklife (24)
Date
Today (128)
Last 7 days (538)
Last 30 days (2572)
Last 365 days (32175)
2026 (17186)
2025 (31989)
2024 (37250)
2023 (42155)
2022 (53499)
2021 (58212)
2020 (57068)
2019 (50437)
2018 (38268)
2017 (35314)
2016 (35492)
2015 (41545)
2014 (35734)
2013 (31242)
2012 (33335)
2011 (33803)
2010 (32508)
Location
Africa (983)
Alabama (101)
Alaska (7)
Arizona (395)
Arkansas (16)
Asia (46474)
Australia (8303)
California (14455)
Canada (4056)
China (1609)
Colorado (620)
Connecticut (644)
Delaware (446)
Europe (104706)
Florida (2155)
Georgia (467)
Hawaii (3)
Idaho (69)
Illinois (1247)
India (103)
Indiana (650)
Iowa (27)
Japan (618)
Kansas (141)
Kentucky (55)
Louisiana (61)
Maine (76)
Maryland (1730)
Massachusetts (10517)
Michigan (400)
Minnesota (802)
Mississippi (7)
Missouri (163)
Montana (36)
Nebraska (30)
Nevada (154)
New Hampshire (91)
New Jersey (3808)
New Mexico (34)
New York (3816)
North Carolina (1916)
North Dakota (10)
Northern California (7265)
Ohio (437)
Oklahoma (24)
Oregon (46)
Pennsylvania (2851)
Puerto Rico (32)
Rhode Island (55)
South America (1363)
South Carolina (89)
South Dakota (2)
Southern California (5711)
Tennessee (239)
Texas (2335)
United States (51466)
Utah (433)
Vermont (2)
Virginia (363)
Washington D.C. (87)
Washington State (1177)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
812,556 Results for "hemaflo therapeutics inc formerly known as drp medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
June 30, 2026
·
8 min read
Press Releases
Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office
April 27, 2026
·
7 min read
Press Releases
Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer
April 21, 2026
·
8 min read
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic
June 30, 2025
·
5 min read
Press Releases
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
July 16, 2025
·
5 min read
Press Releases
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
June 30, 2026
·
6 min read
Press Releases
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
March 19, 2026
·
4 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
·
5 min read
1 of 81,256
Next
